Ethics
![Picture](/uploads/1/9/0/5/19057073/369373864.gif)
There are several ethical issues surrounding the topic of hemophilia. Primarily the fact that there is a lack of global access to care as well as the access to new technologies in aid of this. Hemophilia is a very extreme blood disorder that doesn't receive the amount of attention it deserves. In most developing countries it is neglected as it is viewed as a secondary problem in comparison to malaria and poverty. The truth is hemophilia is a very important yet controversial topic that must be addressed. Due to several resource constraints, treatment for hemophilia is unable to attend to all those who suffer from it. Wealthy countries such the US and Canada are able to fund research efforts in search of effective treatments where as those in developing countries cannot even afford food. The fact that aid isn't being given to these helpless countries sparks controversy around the world.
With this in mind, the use of animal trials are also a very controversial aspect of the topic. Experimenting with animals in trials to test treatments and medication provokes many to question the humanity of people. Placing animals in such restricted environments to be tested upon is unethical. People believe that exploring methods in which do not involve the use of animals are essential. The draw back of this however would include how progress wouldn't be as efficient without the use of a living organism to test things out. It would take much longer to find therapies that can benefit hemophiliacs.
In addition, the use of human blood in replacement therapy also sparks controversy and the health aspect of the issues. Using blood from other donors can cause a spread of a potential disease from the original carrier. Although the blood does get treated for infectious diseases, people question the guarantee of clean blood. Finding other sources of clotting factors are essential in erasing this controversy however, using human blood is the best and most efficient way in re-building the little to no clotting factor in hemophiliacs.
With this in mind, the use of animal trials are also a very controversial aspect of the topic. Experimenting with animals in trials to test treatments and medication provokes many to question the humanity of people. Placing animals in such restricted environments to be tested upon is unethical. People believe that exploring methods in which do not involve the use of animals are essential. The draw back of this however would include how progress wouldn't be as efficient without the use of a living organism to test things out. It would take much longer to find therapies that can benefit hemophiliacs.
In addition, the use of human blood in replacement therapy also sparks controversy and the health aspect of the issues. Using blood from other donors can cause a spread of a potential disease from the original carrier. Although the blood does get treated for infectious diseases, people question the guarantee of clean blood. Finding other sources of clotting factors are essential in erasing this controversy however, using human blood is the best and most efficient way in re-building the little to no clotting factor in hemophiliacs.